Dialyzable leukocyte extract
Dialyzable leukocyte extract has been studied in 1 paper since 1984: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 31, 1984: “Effects of long-term treatment of mice with anti-I-J monoclonal antibody and dialyzable leukocyte extract on immune function and lifespan”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Medical University of South Carolina and 1 more
- Animals1
What did studies of Dialyzable leukocyte extract find?
2Studies of Dialyzable leukocyte extract measured 2 outcomes; the most studied are secondary antibody response (1 study) and nonspecific suppressor cell activity (1).
Secondary antibody response
upin mice1
1 study
Secondary antibody response
upin mice1
Dialyzable leukocyte extract increases secondary antibody response in mice.
“Both types of immunologic intervention resulted in a greater secondary antibody response than that of the saline-treated control mice.”
Animalsimmunized with avian gammaglobulin at 27 and 29 months of age
Mechanisms of ageing and development
Nonspecific suppressor cell activity
downin mice1
1 study
Nonspecific suppressor cell activity
downin mice1
Dialyzable leukocyte extract decreases nonspecific suppressor cell activity in mice.
“Treatment with dialyzable leukocyte extract decreased the elevated nonspecific suppressor activity.”
Animalstreated once a week for one yearspleen1 year
Mechanisms of ageing and development